Vanguard Group’s Tenax Therapeutics TENX Stock Holding History

Vanguard Group’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3.12M	Buy	255,664 +93,864	+58%	+$816K	﹤0.01%	3420
2025 Q3	$1.23M	Buy	161,800 +139,513	+626%	+$852K	﹤0.01%	3726
2025 Q2	$130K	Hold	22,287	–	–	﹤0.01%	4122
2025 Q1	$146K	Hold	22,287	–	–	﹤0.01%	4100
2024 Q4	$138K	Buy	+22,287	New	+$108K	﹤0.01%	4140
2024 Q1	–	Sell	-2,326	Closed	-$51.1K	–	4481
2023 Q4	$51.1K	Buy	+2,326	New	+$55.8K	﹤0.01%	4369
2023 Q1	–	Sell	-109	Closed	-$19.4K	–	4577
2022 Q4	$19.4K	Hold	109	–	–	﹤0.01%	4496
2022 Q3	$30K	Sell	109 -115	-51%	-$46.1K	﹤0.01%	4573
2022 Q2	$108K	Hold	224	–	–	﹤0.01%	4540
2022 Q1	$290K	Sell	224 -1	-0.4%	-$1.11K	﹤0.01%	4476
2021 Q4	$374K	Sell	225 -2	-0.9%	-$4.5K	﹤0.01%	4480
2021 Q3	$642K	Buy	227 +4	+2%	+$10.5K	﹤0.01%	4340
2021 Q2	$742K	Buy	223 +112	+101%	+$355K	﹤0.01%	4204
2021 Q1	$338K	Buy	111 +78	+236%	+$278K	﹤0.01%	4191
2020 Q4	$99K	Buy	33 +8	+32%	+$14.7K	﹤0.01%	4144
2020 Q3	$61K	Buy	25 +17	+213%	+$36.3K	﹤0.01%	4056
2020 Q2	$11K	Hold	8	–	–	﹤0.01%	4070
2020 Q1	$7K	Hold	8	–	–	﹤0.01%	4076
2019 Q4	$17K	Hold	8	–	–	﹤0.01%	4097
2019 Q3	$15K	Hold	8	–	–	﹤0.01%	4137
2019 Q2	$17K	Hold	8	–	–	﹤0.01%	4152
2019 Q1	$25K	Hold	8	–	–	﹤0.01%	4095
2018 Q4	$15K	Hold	8	–	–	﹤0.01%	4134
2018 Q3	$65K	Hold	8	–	–	﹤0.01%	4107
2018 Q2	$78K	Hold	8	–	–	﹤0.01%	4072
2018 Q1	$70K	Buy	+8	New	+$92.1K	﹤0.01%	4055
2017 Q4	–	Sell	-17	Closed	-$231K	–	4058
2017 Q3	$193K	Sell	17 -15	-47%	-$223K	﹤0.01%	3929
2017 Q2	$751K	Sell	32 -5	-14%	-$83.2K	﹤0.01%	3641
2017 Q1	$658K	Buy	37 +8	+28%	+$291K	﹤0.01%	3695
2016 Q4	$1.78M	Sell	29 -1	-3%	-$58.7K	﹤0.01%	3396
2016 Q3	$2.24M	Hold	30	–	–	﹤0.01%	3344
2016 Q2	$2.49M	Sell	30 -1	-3%	-$83.4K	﹤0.01%	3293
2016 Q1	$2.02M	Hold	31	–	–	﹤0.01%	3379
2015 Q4	$3.22M	Hold	31	–	–	﹤0.01%	3201
2015 Q3	$2.96M	Buy	31 +1	+3%	+$114K	﹤0.01%	3203
2015 Q2	$3.6M	Hold	30	–	–	﹤0.01%	3162
2015 Q1	$3.15M	Hold	30	–	–	﹤0.01%	3213
2014 Q4	$3.65M	Buy	30 +20	+200%	+$2.42M	﹤0.01%	3047
2014 Q3	$1.29M	Buy	10 +7	+233%	+$898K	﹤0.01%	3428
2014 Q2	$404K	Buy	3 +1	+50%	+$154K	﹤0.01%	3733
2014 Q1	$279K	Buy	+2	New	+$396K	﹤0.01%	3763

Other funds holding TENX

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Group's TENX Position: Q4 2025 in Review

Vanguard Group increased its Tenax Therapeutics (TENX) stake by 58% in Q4 2025, buying an estimated $816K and bringing the position to 255,664 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3420.

Vanguard Group first reported a position in TENX in Q1 2014 and has held it in 41 quarters since. The position peaked at $3.65M in Q4 2014. 48 funds tracked by Wall St. Rank hold TENX as of Q4 2025.

Vanguard Group held 255,664 shares of Tenax Therapeutics worth $3.12M as of Q4 2025.
Vanguard Group bought 93,864 Tenax Therapeutics shares in Q4 2025, an estimated $816K.
Tenax Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3420 holding.
Vanguard Group first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 41 quarters since.
Vanguard Group's Tenax Therapeutics position peaked at $3.65M in Q4 2014.
48 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.